The influence of disease activity on fatigue in patients with ulcerative colitis – a longitudinal study

References

• Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2010;16(2):338–346.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007;56(4):453–455.
   PubMed Web of Science ®Google Scholar
• Danese S, Roda G, Peyrin-Biroulet L. Evolving therapeutic goals in ulcerative colitis: towards disease clearance. Nat Rev Gastroenterol Hepatol. 2020;17(1):1–2.
   PubMed Web of Science ®Google Scholar
• Zallot C, Peyrin-Biroulet L. Deep remission in inflammatory bowel disease: looking beyond symptoms. Curr Gastroenterol Rep. 2013;15(3):315.
   PubMedGoogle Scholar
• Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol. 1996;9(6):456–460.
   PubMed Web of Science ®Google Scholar
• Kreijne JE, Lie MR, Vogelaar L, et al. Practical guideline for fatigue management in inflammatory bowel disease. J Crohns Colitis. 2016;10(1):105–111.
   PubMed Web of Science ®Google Scholar
• Grimstad T, Norheim KB, Isaksen K, et al. Fatigue in newly diagnosed inflammatory bowel disease. J Crohns Colitis. 2015;9(9):725–730.
   PubMed Web of Science ®Google Scholar
• Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16(4):247–259.
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29(2):247–264.
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Long MD, Martin C, et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12(8):1315–1323.
   PubMed Web of Science ®Google Scholar
• Romberg-Camps MJ, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in The Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010;16(12):2137–2147.
   PubMed Web of Science ®Google Scholar
• Graff LA, Clara I, Walker JR, et al. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors. Clin Gastroenterol Hepatol. 2013;11(9):1140–1146.
   PubMed Web of Science ®Google Scholar
• Jonefjall B, Simren M, Lasson A, et al. Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. United European Gastroenterol J. 2018;6(1):148–158.
   PubMed Web of Science ®Google Scholar
• Villoria A, Garcia V, Dosal A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLOS One. 2017;12(7):e0181435.
   PubMed Web of Science ®Google Scholar
• Lesage AC, Hagege H, Tucat G, et al. Results of a national survey on quality of life in inflammatory bowel diseases. Clin Res Hepatol Gastroenterol. 2011;35(2):117–124.
   PubMed Web of Science ®Google Scholar
• Chavarria C, Casanova MJ, Chaparro M, et al. Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study. J Crohns Colitis. 2019;13(8):996–1002.
   PubMed Web of Science ®Google Scholar
• Casellas F, Barreiro de Acosta M, Iglesias M, et al. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012;24(7):762–769.
   PubMed Web of Science ®Google Scholar
• Grimstad T, Norheim KB, Kvaloy JT, et al. Conventional treatment regimens for ulcerative colitis alleviate fatigue – an observational cohort study. Scand J Gastroenterol. 2016;51(10):1213–1219.
   PubMed Web of Science ®Google Scholar
• Minderhoud IM, Oldenburg B, van Dam PS, et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol. 2003;98(5):1088–1093.
   PubMed Web of Science ®Google Scholar
• Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
   PubMed Web of Science ®Google Scholar
• Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol. 2004;31:1896–1902.
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123.
   PubMed Web of Science ®Google Scholar
• Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol rheumatoid arthritis fatigue multi-dimensional questionnaire (BRAF MDQ), Bristol rheumatoid arthritis fatigue numerical rating scales (BRAF NRS) for severity, effect, and coping, chalder fatigue questionnaire (CFQ), checklist individual strength (CIS20R and CIS8R), fatigue severity scale (FSS), functional assessment chronic illness therapy (fatigue) (FACIT-F), Multi-Dimensional assessment of fatigue (MAF), multi-dimensional fatigue inventory (MFI), pediatric quality of life (PedsQL) multi-dimensional fatigue scale, profile of fatigue (ProF), short form 36 vitality subscale (SF-36 VT), and visual analog scales (VAS). Arthritis Care Res. 2011;63(Suppl 11):S263–S286.
   Google Scholar
• Dagfinrud H, Vollestad NK, Loge JH, et al. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum. 2005;53(1):5–11.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–1666.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629.
   PubMed Web of Science ®Google Scholar
• Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7(1):15–29.
   PubMed Web of Science ®Google Scholar
• Krajewska-Włodarczyk M, Owczarczyk-Saczonek A, Placek W. Fatigue – an underestimated symptom in psoriatic arthritis. Reumatologia. 2017;55(3):125–130.
   PubMedGoogle Scholar
• Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;10:1827.
   PubMed Web of Science ®Google Scholar
• Corominas H, Alegre C, Narváez J, et al. Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study. Medicine. 2019;98(26):e15947.
   PubMed Web of Science ®Google Scholar
• Larssen E, Brede C, Hjelle A, et al. Fatigue in primary Sjögren's syndrome: a proteomic pilot study of cerebrospinal fluid. SAGE Open Med. 2019;7:2050312119850390.
   Web of Science ®Google Scholar
• Bager P, Befrits R, Wikman O, et al. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther. 2012;35(1):133–141.
   PubMed Web of Science ®Google Scholar
• Singh S, Blanchard A, Walker JR, et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2011;9(9):769–775.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJ, Sood R, et al. Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. Am J Gastroenterol. 2016;111(4):541–551.
   PubMed Web of Science ®Google Scholar
• Grimstad T, Kvivik I, Kvaloy JT, et al. Heat-shock protein 90α in plasma reflects severity of fatigue in patients with Crohn's disease. Innate Immun. 2020;26(2):146–151.
   PubMed Web of Science ®Google Scholar
• Bardsen K, Nilsen MM, Kvaloy JT, et al. Heat shock proteins and chronic fatigue in primary Sjögren's syndrome. Innate Immun. 2016;22(3):162–167.
   PubMed Web of Science ®Google Scholar
• Norheim KB, Jonsson G, Omdal R. Biological mechanisms of chronic fatigue. Rheumatology. 2011;50(6):1009–1018.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Bala M, Han C, et al. Infliximab improves quality of life in patients with Crohn's disease. Inflamm Bowel Dis. 2002;8:237–243.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 2003;48(1):35–45.
   PubMed Web of Science ®Google Scholar
• Almeida C, Choy EH, Hewlett S, et al. Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2016;(6):CD008334.
   Google Scholar
• Skoie IM, Dalen I, Omdal R. Effect of biological treatment on fatigue in psoriasis: a systematic review and meta-analysis. Am J Clin Dermatol. 2019;20:493–502.
   PubMed Web of Science ®Google Scholar
• Omdal R. The biological basis of chronic fatigue: neuroinflammation and innate immunity. Curr Opin Neurol. 2020;33(3):391–396.
   PubMed Web of Science ®Google Scholar